SEO URLwww.firestrike.ai/deals/ardelyx-zydus-lifesciences-acquisition-2026
acquisitionAnnounced · Jan 21, 2026Chemical Manufacturing (325)Source · Unverified ReportsArticle · Factual
Zydus Lifesciences acquires Ardelyx
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
—
Target
Ardelyx
NASDAQ: ARDX · Waltham, Massachusetts
Acquirer
Zydus Lifesciences
Financial Stake
Status
Pending
Zydus Lifesciences agreed to acquire Ardelyx. Reported deal value: Undisclosed. Status: Pending. Sector: Not specified. Target headquarters context: Waltham, Massachusetts, United States.
This page summarizes publicly available information about the transaction as of 2026-01-21. Figures and status may change as filings and press coverage update.
Zydus Lifesciences plans to acquire Ardelyx for USD 2.5B January 21, 2026 Zydus Lifesciences is evaluating acquisition of a majority stake in US-based Ardelyx Inc. , with the deal likely to be valued at $2.2–2.5 billion
Deal timeline
Announced
Jan 21, 2026 · medicalbuyer.co.in
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Chemical Manufacturing (325). Figures and status may change as sources update.
Sources: medicalbuyer.co.in · Primary article · FireStrike proprietary index